Given the superiority of sirolimus in suppressing the growth of transplanted nf1/pten-mutant melanomas while inducing autophagy in normal tissues, we faced a major challenge: to identify drugs that could selectively cause apoptosis in sirolimus-sensitized melanoma cells. Here, PTEN is linked to melanoma.